Explore

Trendline Trendline
IGC Pharma Expands Alzheimer's Trial with New Site in Dallas, Enhancing Patient Access

IGC Pharma Expands Alzheimer's Trial with New Site in Dallas, Enhancing Patient Access

IGC Pharma Expands Alzheimer's Trial with New Site in Dallas, Enhancing Patient Access
Trendline Trendline
Hewlett Foundation Advocates for Philanthropy in Bridging AI Governance Gap Between Washington and Silicon Valley

Hewlett Foundation Advocates for Philanthropy in Bridging AI Governance Gap Between Washington and Silicon Valley

Hewlett Foundation Advocates for Philanthropy in Bridging AI Governance Gap Between Washington and Silicon Valley
Trendline Trendline
IGC Pharma Expands Alzheimer's Drug Trial with New Site in Dallas

IGC Pharma Expands Alzheimer's Drug Trial with New Site in Dallas

IGC Pharma Expands Alzheimer's Drug Trial with New Site in Dallas
Trendline Trendline
Thryv Therapeutics Begins Patient Dosing in Long QT Syndrome Study with FDA Fast Track Designation

Thryv Therapeutics Begins Patient Dosing in Long QT Syndrome Study with FDA Fast Track Designation

Thryv Therapeutics Begins Patient Dosing in Long QT Syndrome Study with FDA Fast Track Designation
Trendline Trendline
Allogeneic Cell Therapy Market Projected to Reach USD 5968.77 Million by 2035

Allogeneic Cell Therapy Market Projected to Reach USD 5968.77 Million by 2035

Allogeneic Cell Therapy Market Projected to Reach USD 5968.77 Million by 2035
Trendline Trendline
Inhibrx Announces Webcast for Clinical Update on Ozekibart in Colorectal Cancer

Inhibrx Announces Webcast for Clinical Update on Ozekibart in Colorectal Cancer

Inhibrx Announces Webcast for Clinical Update on Ozekibart in Colorectal Cancer
Trendline Trendline
Novo Nordisk Advances Regulatory Filings for Sickle Cell Drug Etavopivat Following Positive Trial Results

Novo Nordisk Advances Regulatory Filings for Sickle Cell Drug Etavopivat Following Positive Trial Results

Novo Nordisk Advances Regulatory Filings for Sickle Cell Drug Etavopivat Following Positive Trial Results
Trendline Trendline
Pfizer Presents Oncology Innovations at ASCO 2026, Highlighting New Cancer Treatment Strategies

Pfizer Presents Oncology Innovations at ASCO 2026, Highlighting New Cancer Treatment Strategies

Pfizer Presents Oncology Innovations at ASCO 2026, Highlighting New Cancer Treatment Strategies
Trendline Trendline
Calluna Pharma Completes Enrollment in Global Phase 2 Study for Pulmonary Fibrosis Treatment

Calluna Pharma Completes Enrollment in Global Phase 2 Study for Pulmonary Fibrosis Treatment

Calluna Pharma Completes Enrollment in Global Phase 2 Study for Pulmonary Fibrosis Treatment
Trendline Trendline
Eluciderm, Inc. Awarded for Innovative ELU42 Research in Wound Healing

Eluciderm, Inc. Awarded for Innovative ELU42 Research in Wound Healing

Eluciderm, Inc. Awarded for Innovative ELU42 Research in Wound Healing
Trendline Trendline
Genentech's Fenebrutinib Shows Promising Results in Reducing Relapses in Multiple Sclerosis

Genentech's Fenebrutinib Shows Promising Results in Reducing Relapses in Multiple Sclerosis

Genentech's Fenebrutinib Shows Promising Results in Reducing Relapses in Multiple Sclerosis
Trendline Trendline
Arrowhead Pharmaceuticals Anticipates Further Stock Gains Amid Clinical Trial Developments

Arrowhead Pharmaceuticals Anticipates Further Stock Gains Amid Clinical Trial Developments

Arrowhead Pharmaceuticals Anticipates Further Stock Gains Amid Clinical Trial Developments